This central price target is derived from 13 individually verified analyst targets, not a single published consensus figure. The targets reviewed range from $175 at Citi to $250 at Wells Fargo, producing a mean of about $219 that rounds to a clean $220. That dispersion is meaningful: it signals genuine disagreement rather than a unified "analyst consensus."
The bullish camp has been actively raising targets after Cintas's strong fiscal first-quarter results. Argus Research raised its target to $240, Goldman Sachs to $239, UBS to $235, Truist to $230, and Bank of America upgraded the shares to Buy with a $230 target. These firms generally point to a more macro-resilient revenue model than the market credits, durable organic growth, and multi-year earnings leverage from the UniFirst deal.
The cautious camp is anchored by valuation. Stifel holds a $190 target, Bernstein a $200 target, and RBC Capital $206, all rating the stock Hold. Citi's Sell rating carries the lowest target at $175, raised from $160, reflecting concern that Cintas's premium multiple leaves little room for error. The average of these targets should be read as a statistical midpoint, not a guarantee.
As of the early-October session, CTAS closed near $193.02, down from a 52-week high of $219.17 reached in late July. Reaching $220 would require a gain of roughly 14% from current levels — a substantial move that would also take the stock just above its prior all-time-high zone.
The path to such a level would likely depend on continued high-single-digit organic growth, sustained margin expansion, and a smooth integration of UniFirst (UNF). Cintas reported fiscal first-quarter revenue of $3.01 billion, up 10.9%, with organic growth of 8.9%, adjusted EPS (earnings per share) up 15.8% to $1.39, and a record 51.5% gross margin. Management raised full-year fiscal 2027 guidance to revenue of $12.15–$12.27 billion and adjusted EPS of $5.45–$5.54.
Several verified factors support the upside case. Cintas operates a recurring, route-based service model with strong customer retention and cross-selling across uniforms, first aid, safety, and fire protection. First Aid and Safety grew organically 14.2% in the latest quarter, outpacing the 8% growth in Uniform Rental and Facility Services.
The roughly $5.5 billion acquisition of UniFirst is a key catalyst, with management targeting about $375 million in operating cost synergies and a close before the end of calendar 2026. Analysts at Truist and Bank of America explicitly cite the deal as a multi-year earnings driver. Cintas is also a dividend growth stalwart, having raised its payout for more than four decades.
The principal risk is valuation. At roughly 36x forward earnings, CTAS trades at a substantial premium to business-services peers and to its own long-term average. That leaves the stock exposed to multiple compression if growth or margins disappoint, and management itself cautioned that quarterly growth will not be linear.
The UniFirst transaction remains under a second request from the U.S. Federal Trade Commission, adding regulatory and integration uncertainty; fiscal 2027 guidance notably excludes the deal's contribution. Slowing labor-market conditions in Cintas's customer industries, higher energy and fuel costs, and any faltering in retention or new-business wins could also weigh on the share price and the average analyst price target.
CTAS has traded in a 52-week range of $161.16 to $219.17. The $219–$220 area is significant because it coincides with the July high and a round-number psychological level, making it a natural resistance zone on any recovery toward the target. On the downside, the stock has recently consolidated near $190–$196, an area that has provided support after the post-earnings pullback. A decisive break above $220 would require clearing both the prior high and this resistance level.
Most analyst price targets reflect a research horizon of roughly 12 months, though individual firms apply their own frameworks and timelines. Investors should watch Cintas's next earnings report, expected in mid-December, for confirmation of organic growth and margin trends; any Federal Trade Commission decision on the UniFirst deal; and subsequent analyst revisions. Guidance updates, labor-market data, and energy costs are also relevant to the outlook.
For traders who want a more continuous read on a name like Cintas, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to traditional analyst research. The tool uses artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single quarterly report, traders can use it to discover opportunities, track positions, and spot shifting trends more efficiently. Explore the AI Daily Buy/Sell Signals to see how it can fit into your routine.
Can Cintas reach $220? The $220 figure is the rounded average of 13 current analyst targets, roughly 14% above the latest price. It sits just above the stock's prior all-time high, making it a meaningful but plausible extension of the recent range. The supporting case rests on durable organic growth, record profitability, raised guidance, and UniFirst synergies, while the obstacles are a demanding valuation multiple and unresolved deal and regulatory execution. With targets spanning $175 to $250, analyst disagreement is genuine, and neither the highest nor lowest figure should be treated as more probable. The answer ultimately depends less on whether Cintas keeps executing and more on whether investors continue to pay a premium multiple for that execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CTAS has been loosely correlated with EXPO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CTAS jumps, then EXPO could also see price increases.
| Ticker / NAME | Correlation To CTAS | 1D Price Change % | ||
|---|---|---|---|---|
| CTAS | 100% | +1.23% | ||
| EXPO - CTAS | 62% Loosely correlated | +2.15% | ||
| UNF - CTAS | 53% Loosely correlated | +0.44% | ||
| VRSK - CTAS | 51% Loosely correlated | -0.37% | ||
| ARLO - CTAS | 47% Loosely correlated | -1.49% | ||
| EFX - CTAS | 46% Loosely correlated | +1.86% | ||
More | ||||
| Ticker / NAME | Correlation To CTAS | 1D Price Change % |
|---|---|---|
| CTAS | 100% | +1.23% |
| Office Equipment/Supplies industry (46 stocks) | 13% Poorly correlated | +0.57% |
| Producer Manufacturing industry (350 stocks) | 8% Poorly correlated | -0.40% |